INS and metabolic syndrome: In contrast, Group 2 consisted of patients with a mean age of 54 years, multiple comorbidities including hypertension (66%) and dyslipidemia (38%), and all patients were diagnosed with diabetes and treated either with oral hypoglycemic medication or insulin.